105 related articles for article (PubMed ID: 4091648)
1. Pharmacokinetics and toxicity of the oxime HGG 12 in dogs.
Klimmek R; Eyer P
Arch Toxicol; 1985 Sep; 57(4):237-42. PubMed ID: 4091648
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.
Klimmek R; Eyer P
Arch Toxicol; 1986 Dec; 59(4):272-8. PubMed ID: 3827595
[TBL] [Abstract][Full Text] [Related]
3. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
Simons KJ; Briggs CJ
J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of HI-6 in beagle dogs.
Simons KJ; Briggs CJ
Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
[TBL] [Abstract][Full Text] [Related]
5. Oral forms of the oxime HI-6: a study of pharmacokinetics and tolerance after administration to healthy volunteers.
Jovanovic D; Maksimovic M; Joksovic D; Kovacevic V
Vet Hum Toxicol; 1990 Oct; 32(5):419-21. PubMed ID: 2238436
[TBL] [Abstract][Full Text] [Related]
6. Formation of cyanide after i.v. administration of the oxime HI 6 to dogs.
Eyer P; Kawan A; Ladstetter B
Arch Toxicol; 1987; 61(1):63-9. PubMed ID: 3439876
[TBL] [Abstract][Full Text] [Related]
7. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
Lukey BJ; Woodard CL; Clark CR; McCluskey MP
J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
[TBL] [Abstract][Full Text] [Related]
8. Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs.
Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1994 Sep; 24(3):443-53. PubMed ID: 7528301
[TBL] [Abstract][Full Text] [Related]
9. Safety and toxicology assessment of sodium nitrite administered by intramuscular injection.
Miller L; Hébert CD; Grimes SD; Toomey JS; Oh JY; Rose JJ; Patel RP
Toxicol Appl Pharmacol; 2021 Oct; 429():115702. PubMed ID: 34464673
[TBL] [Abstract][Full Text] [Related]
10. HI-6 in man: blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers.
Kusić R; Bosković B; Vojvodić V; Jovanović D
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S89-97. PubMed ID: 4092899
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
Lee FW; Salmonson T; Metzler CH; Benet LZ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
[TBL] [Abstract][Full Text] [Related]
12. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
[TBL] [Abstract][Full Text] [Related]
13. Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs.
Devcic A; Schmeling WT; Kampine JP; Warltier DC
Anesthesiology; 1994 Aug; 81(2):419-30. PubMed ID: 8053593
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE
J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
[TBL] [Abstract][Full Text] [Related]
15. Effects of atropine and soman on the pharmacokinetics of the oxime HLö 7 dimethanesulfonate in anesthetized guinea-pigs.
Worek F; Klimmek R; Szinicz L
Drug Chem Toxicol; 1995; 18(2-3):137-49. PubMed ID: 7497908
[TBL] [Abstract][Full Text] [Related]
16. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of thiamphenicol in dogs.
Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
20. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
